4.3 Review

Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation

期刊

CURRENT OPINION IN CRITICAL CARE
卷 18, 期 5, 页码 460-471

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MCC.0b013e32835685ad

关键词

critical care; extracorporeal membrane oxygenation; pharmacokinetics; renal replacement therapy; sustained low-efficiency dialysis

资金

  1. Janssen-Cilag
  2. Astra Zeneca
  3. Novartis
  4. Australian National Health and Medical Research Council of Australia (Australian Based Health Professional Research Fellowship) [569917]

向作者/读者索取更多资源

Purpose of review Antibiotic dosing for critically ill patients that is derived from other patient groups is likely to be suboptimal because of significant antibiotic pharmacokinetic changes, particularly in terms of drug volume of distribution and clearance. Organ support techniques including renal replacement therapy (RRT) and extracorporeal membrane oxygenation (ECMO) increase the pharmacokinetic variability. This article reviews the recently published antibiotic pharmacokinetic data associated with burns patients, those receiving continuous RRT (CRRT), sustained low-efficiency dialysis (SLED) and ECMO. Recent findings These groups develop increases in volume of distribution that necessitate the use of higher initial doses to rapidly achieve therapeutic antibiotic concentrations. Burns patients have supranormal drug clearances requiring more frequent administration of antibiotics. Patients receiving CRRT or SLED have variable drug clearances related to different equipment and RRT settings at different institutions. ECMO presents a different challenge because there is such a dearth of data with higher than standard doses potentially required, even in the presence of end-organ failure. Summary In the context of such variable pharmacokinetics, a guideline approach to dosing remains elusive because of insufficient available data and, therefore, use of therapeutic drug monitoring should be considered advantageous where possible.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial

Amy Legg, Niamh Meagher, Sandra A. Johnson, Matthew A. Roberts, Alan Cass, Marc H. Scheetz, Jane Davies, Jason A. Roberts, Joshua S. Davis, Steven Y. C. Tong

Summary: The clinical risk factors for nephrotoxicity in Staphylococcus aureus bacteraemia are still unclear. In a clinical trial comparing standard therapy to combination therapy, it was found that the combination therapy group had a significantly higher incidence of acute kidney injury.

CLINICAL DRUG INVESTIGATION (2023)

Article Medical Laboratory Technology

Clearance of Piperacillin-Tazobactam and Vancomycin During Continuous Renal Replacement With Regional Citrate Anticoagulation

Lucy Sharrock, Melissa J. Ankravs, Adam M. Deane, Thomas Rechnitzer, Steven C. Wallis, Jason A. Roberts, Rinaldo Bellomo

Summary: This study measured the clearance of piperacillin-tazobactam and vancomycin in patients receiving CVVHDF with regional citrate anticoagulation, and found that both drugs have high clearance, providing key information for optimal dosing.

THERAPEUTIC DRUG MONITORING (2023)

Article Infectious Diseases

Accuracy of a precision dosing software program for predicting antibiotic concentrations in critically ill patients

Ming G. Chai, Jason A. Roberts, Andras Farkas, Menino O. Cotta

Summary: This study demonstrates that precision dosing software programs can reasonably predict antibiotic concentrations in critically ill patients with sepsis. The addition of therapeutic drug monitoring (TDM) data improves the predictive performance of the software for all three antibiotics and the ability to anticipate the correct dose change required.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Review Virology

Mpox diagnostics: Review of current and emerging technologies

Chuan Kok Lim, Jason Roberts, Michael Moso, Kwee Chin Liew, Mona L. Taouk, Eloise Williams, Thomas Tran, Eike Steinig, Leon Caly, Deborah Ann Williamson

Summary: This review discusses the changes in the epidemiology of monkeypox and the advancements in the understanding of its virology and viral dynamics relevant to diagnostics. It outlines the traditional and emerging laboratory technologies useful for monkeypox virus detection and in guiding elimination strategies. Importantly, the development in MPXV genomics has rapidly advanced our understanding of viral evolution and adaptation in the current outbreak.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Pharmacology & Pharmacy

In silico evaluation of a beta-lactam dosing guideline among adults with serious infections

Paul Williams, Menino Osbert Cotta, Mohd H. H. Abdul-Aziz, Kathryn Wilks, Andras Farkas, Jason A. A. Roberts

Summary: This study aimed to compare the achievement of therapeutic PK-PD exposure targets for beta-lactam antibiotics using product information dosing or guideline-based dosing for serious infections. In silico simulations were performed, and the results showed that guideline-based dosing had significantly higher probability of target attainment at 48 and 96 hours compared to product information dosing. The study also found that eGFR was significantly associated with the %PTA by guideline-based dosing.

PHARMACOTHERAPY (2023)

Article Urology & Nephrology

Serum Creatinine and Tacrolimus Assessment With VAMS Finger-Prick Microsampling: A Diagnostic Test Study

Carla E. Scuderi, Suzanne L. Parker, Margaret Jacks, George T. John, Brett McWhinney, Jacobus Ungerer, Andrew J. Mallett, Helen G. Healy, Jason A. Roberts, Christine E. Staatz

Summary: This study aimed to assess the diagnostic accuracy of using volumetric absorptive microsamplers (VAMS) to measure tacrolimus and creatinine in kidney transplant recipients. The results showed that VAMS can reliably measure tacrolimus and creatinine, providing a less invasive and more frequent sampling method for patients.

KIDNEY MEDICINE (2023)

Article Microbiology

Population Pharmacokinetic and Pharmacodynamic Analysis of Valganciclovir for Optimizing Preemptive Therapy of Cytomegalovirus Infections in Kidney Transplant Recipients

Pier Giorgio Cojutti, Aaron J. Heffernan, Thomas Tangden, Paola Della Siega, Carlo Tascini, Jason A. Roberts, Federico Pea

Summary: This study aimed to develop a population pharmacokinetic/pharmacodynamic (PK/PD) model of valganciclovir for preemptive therapy of cytomegalovirus (CMV) infection in kidney transplant patients. Ganciclovir concentrations and CMV viral loads were retrospectively obtained from kidney transplant patients. Monte Carlo simulations were conducted to assess the probability of attaining viral load targets, and a PK/PD model was devised.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Article Biochemical Research Methods

Stability of nafamostat in intravenous infusion solutions, human whole blood and extracted plasma: implications for clinical effectiveness studies

Maria Patricia Hernandez-Mitre, Hayoung Won, Steven C. Wallis, Suzanne L. Parker, Jason A. Roberts

Summary: The aim of this study was to investigate the stability of nafamostat in infusion solutions, during blood sample collection, and in extracted plasma samples in the autosampler. Nafamostat was found to be stable in infusion solutions and in whole blood collected in sodium fluoride/potassium oxalate tubes at 4 degrees C for up to 3 hours before centrifugation. However, nafamostat degraded at a rate of 4.7 +/- 0.7% per hour in extracted plasma samples in the autosampler. In conclusion, viable samples can be obtained using appropriate collection tubes and prompt processing.

BIOANALYSIS (2023)

Review Pharmacology & Pharmacy

Therapeutic drug monitoring of carbapenem antibiotics in critically ill patients: an overview of principles, recommended dosing regimens, and clinical outcomes

Gavin Matthew Joynt, Lowell Ling, Wai Tat Wong, Jeffrey Lipman

Summary: The importance of antibiotic treatment for sepsis in critically ill septic patients is well known. However, achieving the correct dosage of antibiotics is a challenge. Understanding the pharmacokinetic and pharmacodynamic characteristics of antibiotics in critically ill patients is reshaping how they are dosed.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2023)

Review Infectious Diseases

A Systematic Review on Antimicrobial Pharmacokinetic Differences between Asian and Non-Asian Adult Populations

Eko Setiawan, Menino Osbert Cotta, Jason A. Roberts, Mohd Hafiz Abdul-Aziz

Summary: While inter-ethnic differences in the pharmacokinetic variabilities of antimicrobials have been studied among healthy subjects, further investigation is needed to understand the differences in antimicrobial pharmacokinetics between Asian and non-Asian patients with severe pathologic conditions. A systematic review was conducted to explore the potential variations in antimicrobial pharmacokinetics between Asian and non-Asian populations, with the inclusion of thirty studies on different antimicrobial agents. Inconsistent differences in pharmacokinetic parameters were observed between Asian and non-Asian patients, suggesting that ethnicity may not be a significant predictor in characterizing these differences, and dosing regimens should be adjusted based on demographic or clinical characteristics.

ANTIBIOTICS-BASEL (2023)

Article Infectious Diseases

Is the Pharmacokinetics of First-Line Anti-TB Drugs a Cause of High Mortality Rates in TB Patients Admitted to the ICU? A Non-Compartmental Pharmacokinetic Analysis

Francisco Beraldi-Magalhaes, Suzanne L. L. Parker, Cristina Sanches, Leandro Sousa Garcia, Brenda Karoline Souza Carvalho, Amanda Araujo Costa, Mariana Millan Fachi, Marcus Vinicius de Liz, Alexandra Brito de Souza, Izabella Picinin Safe, Roberto Pontarolo, Steven Wallis, Jeffrey Lipman, Jason A. A. Roberts, Marcelo Cordeiro-Santos

Summary: This study compared the pharmacokinetics of oral rifampin, isoniazid, pyrazinamide, and ethambutol in tuberculosis patients in intensive care units (ICU) and outpatients, and evaluated drug serum concentrations as a potential cause of mortality. The results showed that ICU patients had a lower clearance and volume of distribution for these drugs, and the 30-day mortality rate was 77% compared to an 89% cure rate in outpatients. These differences may reflect changes in organ function, absorption, and distribution to the site of infection in ICU patients, which could impact clinical outcomes.

TROPICAL MEDICINE AND INFECTIOUS DISEASE (2023)

Article Infectious Diseases

Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance

Jason A. Roberts, David P. Nicolau, Ignacio Martin-Loeches, C. Andrew Deryke, Maria C. Losada, Jiejun Du, Munjal Patel, Matthew L. Rizk, Amanda Paschke, Luke F. Chen

Summary: The study aimed to assess the relationship between renal function and the efficacy/safety of imipenem/cilastatin/relebactam for the treatment of HABP/VABP. The results showed that the efficacy of imipenem/cilastatin/relebactam was comparable to piperacillin/tazobactam for participants with various baseline renal functions. However, for participants with normal renal function or CLCR >= 250ml/min, imipenem/cilastatin/relebactam had a higher clinical response rate.

JAC-ANTIMICROBIAL RESISTANCE (2023)

Article Anesthesiology

AUC-based monitoring and model-informed precision dosing of vancomycin in critically ill patients: why and how?

Sylvain Goutelle, Florent Wallet, Yann Thoma, Jean-Remix Peclard, Laurent Bourguignon, Sabine Cohen, Eric Kipnis, Jason Roberts, Bernard Allaouchiche, Arnaud Friggeri

ANAESTHESIA CRITICAL CARE & PAIN MEDICINE (2023)

暂无数据